Open Access

Primary mesenchymal chondrosarcoma of the kidney without HEY1‑NCOA2 and IRF2BP2‑CDX1 fusion: A case report and review

  • Authors:
    • Atsushi Yamagishi
    • Osamu Ichiyanagi
    • Sei Naito
    • Hiromi Ito
    • Takanobu Kabasawa
    • Mitsunori Yamakawa
    • Norihiko Tsuchiya
  • View Affiliations

  • Published online on: November 22, 2019     https://doi.org/10.3892/ol.2019.11143
  • Pages: 885-891
  • Copyright: © Yamagishi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mesenchymal chondrosarcoma (MC) of the kidney is rare. To the best of our knowledge, the current report is the first case of a giant extraskeletal MC that arose primarily from the right kidney and mimicked renal cell carcinoma at the locally advanced stage (cT3bN0) with vena cava thrombus and multiple pulmonary arterial tumor emboli. Additionally, the literature on renal EMC is reviewed and the possibilities of oncogenic heterogeneity are discussed. A 64‑year‑old woman was admitted to Yamagata University Hospital for sudden onset of asymptomatic gross hematuria. CT revealed a 90 mm renal mass without calcification in the right kidney and tumor thrombus extending to the inferior vena cava. Radical nephrectomy with thrombectomy was performed. Lung metastasis was detected 2 months later. The patient received systemic chemotherapy, which was only marginally effective. She died of the malignancy 8 months after surgery. Microscopic examination of the tumor revealed typical histology of MC and a lack of HEY1‑NCOA2 and IRF2BP2‑CDX1 gene fusions in the tumor tissues. Not all MC patients may exhibit chromosomal alterations in the tumor, suggesting the presence of genetically heterogeneous pathways of MC oncogenesis. Further studies are required to confirm the present findings and reinforce the molecular diagnosis of MC.
View Figures
View References

Related Articles

Journal Cover

January-2020
Volume 19 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamagishi A, Ichiyanagi O, Naito S, Ito H, Kabasawa T, Yamakawa M and Tsuchiya N: Primary mesenchymal chondrosarcoma of the kidney without HEY1‑NCOA2 and IRF2BP2‑CDX1 fusion: A case report and review. Oncol Lett 19: 885-891, 2020
APA
Yamagishi, A., Ichiyanagi, O., Naito, S., Ito, H., Kabasawa, T., Yamakawa, M., & Tsuchiya, N. (2020). Primary mesenchymal chondrosarcoma of the kidney without HEY1‑NCOA2 and IRF2BP2‑CDX1 fusion: A case report and review. Oncology Letters, 19, 885-891. https://doi.org/10.3892/ol.2019.11143
MLA
Yamagishi, A., Ichiyanagi, O., Naito, S., Ito, H., Kabasawa, T., Yamakawa, M., Tsuchiya, N."Primary mesenchymal chondrosarcoma of the kidney without HEY1‑NCOA2 and IRF2BP2‑CDX1 fusion: A case report and review". Oncology Letters 19.1 (2020): 885-891.
Chicago
Yamagishi, A., Ichiyanagi, O., Naito, S., Ito, H., Kabasawa, T., Yamakawa, M., Tsuchiya, N."Primary mesenchymal chondrosarcoma of the kidney without HEY1‑NCOA2 and IRF2BP2‑CDX1 fusion: A case report and review". Oncology Letters 19, no. 1 (2020): 885-891. https://doi.org/10.3892/ol.2019.11143